McKesson to acquire controlling interest in Prism VisionMcKesson will purchase an 80% interest for approximately $850 million, while Prism Vision physicians will retain a 20% interest. McKesson Amplify provides funding to state pharmacy associations for advocacyThe funding supports advocacy efforts to elevate and sustain the pharmacy profession. McKesson completes divestiture of Canada-based Rexall, Well.ca The transaction enables McKesson to focus capital deployment and prioritize investments in strategic oncology and biopharma growth platform. McKesson unveils InspiroGene InspiroGene focuses on supporting the commercialization of cell and gene therapies. McKesson to sell Rexall, Well.ca to Birch Hill Equity Partners McKesson said the sale will allow the company to further focus and prioritize investments to grow its oncology and biopharma services platforms. McKesson to acquire controlling interest in Florida Cancer Specialists & Research Institute’s Core Ventures The acquisition enhances McKesson’s integrated oncology platform. 50 Most influential people in retail health Here are the 50 most influential people in retail healthcare. McKesson wraps up ideaShare with new initiative Dreier Pharmacy was named 2024 Health Mart Pharmacy of the Year. HRG’s Wendland to present CE for McKesson ideaShare Wendland will present a CE session titled, “Add Shelf-Life to Your Business: Recommended Practices for Pharmacy Inventory Management.” McKesson launches Project Oasis Project Oasis is intended to improve access to care and advance health equity for at-risk populations in underserved communities. 1 2 3 4 5 Next Last
